Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSORT: Gonal-f Dosing in IVF
NCT00249834Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Sep 2004
- Primary completion
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of follitropin alfa in infertility (8 arms), sponsored by Merck KGaA. Primary endpoint: Number of Oocytes Retrieved. Started Sep 2004; status: completed.
02
Drugs
follitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00249834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249834.